| Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification S Qiu, PS Joshi, MI Miller, C Xue, X Zhou, C Karjadi, GH Chang, AS Joshi, ... Brain 143 (6), 1920-1933, 2020 | 296 | 2020 |
| Newborn infants learn during sleep WP Fifer, DL Byrd, M Kaku, IM Eigsti, JR Isler, J Grose-Fifer, AR Tarullo, ... Proceedings of the National Academy of Sciences 107 (22), 10320-10323, 2010 | 143 | 2010 |
| COVID‐19 in patients with myasthenia gravis P Anand, MCC Slama, M Kaku, C Ong, AM Cervantes‐Arslanian, L Zhou, ... Muscle & nerve 62 (2), 254-258, 2020 | 142 | 2020 |
| Impact of socio-economic factors in delayed reporting and late-stage presentation among patients with cervix cancer in a major cancer hospital in South India M Kaku, A Mathew, B Rajan Asian Pac J Cancer Prev 9 (4), 589-594, 2008 | 113 | 2008 |
| COVID-19-associated risks and effects in myasthenia gravis (CARE-MG) S Muppidi, JT Guptill, S Jacob, Y Li, ME Farrugia, AC Guidon, JO Tavee, ... The Lancet Neurology 19 (12), 970-971, 2020 | 112 | 2020 |
| Multimodal deep learning for Alzheimer’s disease dementia assessment S Qiu, MI Miller, PS Joshi, JC Lee, C Xue, Y Ni, Y Wang, I De Anda-Duran, ... Nature communications 13 (1), 3404, 2022 | 108 | 2022 |
| HIV neuropathy M Kaku, DM Simpson Current opinion in HIV and AIDS 9 (6), 521-526, 2014 | 74 | 2014 |
| A clinician's approach to peripheral neuropathy P Siao, M Kaku Seminars in neurology 39 (05), 519-530, 2019 | 71 | 2019 |
| Neuropathy associated with systemic amyloidosis M Kaku, JL Berk Seminars in Neurology 39 (05), 578-588, 2019 | 65 | 2019 |
| Pathways in the diagnosis and management of diabetic polyneuropathy M Kaku, A Vinik, DM Simpson Current Diabetes Reports 15, 1-16, 2015 | 63 | 2015 |
| Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity M Kaku, DM Simpson Drug design, development and therapy, 1085-1099, 2016 | 46 | 2016 |
| A mixed-methods pilot study of mindfulness-based stress reduction for HIV-associated chronic pain MC George, A Wongmek, M Kaku, A Nmashie, J Robinson-Papp Behavioral Medicine 43 (2), 108-119, 2017 | 43 | 2017 |
| Toward an electrocortical biomarker of cognition for newborn infants JR Isler, AR Tarullo, PG Grieve, E Housman, M Kaku, RI Stark, WP Fifer Developmental science 15 (2), 260-271, 2012 | 33 | 2012 |
| Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25‐year longitudinal study JN Gustine, A Staron, RE Szalat, LM Mendelson, T Joshi, FL Ruberg, ... American journal of hematology 97 (9), 1189-1199, 2022 | 18 | 2022 |
| Peripheral neuropathies AAF Sima, M Blaivas Neuropathology: The Diagnostic Approach. Garcia J., McKeevar P., Sima AAF …, 1997 | 15* | 1997 |
| Neuromuscular complications of HIV infection M Kaku, DM Simpson Handbook of Clinical Neurology 152, 201-212, 2018 | 13 | 2018 |
| Neurological manifestations of hereditary transthyretin amyloidosis: a focus on diagnostic delays MC Kaku, S Bhadola, JL Berk, V Sanchorawala, LH Connors, KHV Lau Amyloid 29 (3), 184-189, 2022 | 9 | 2022 |
| HIV, antiretrovirals, and peripheral neuropathy: A moving target. M Kaku, DM Simpson Muscle & Nerve 57 (3), 347-349, 2017 | 6 | 2017 |
| Droxidopa for treatment of refractory orthostatic hypotension in patients with AL amyloidosis: A case series JNR Lopez, LM Mendelson, T Joshi, D Hughes, MC Kaku, ... Blood 138, 4737, 2021 | 4 | 2021 |
| Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis VP Nguyen, D Brauneis, M Kaku, JM Sloan, S Sarosiek, K Quillen, ... Bone Marrow Transplantation 53 (3), 371-373, 2018 | 4 | 2018 |
